NeuroAiD™ should be taken in addition to prevention drugs that are commonly prescribed by your doctor; these typically include antiplatelet, antihypertensive, and cholesterol-lowering drugs, among others.
To date, no drug interactions with NeuroAiD™ have been reported. Systematic clinical trials have shown that NeuroAiD™ does not have any interaction with aspirin. Patients taking NeuroAiD™ with anticoagulants have reportedly shown no impact on their INR (International Normalized Ratio). Nevertheless, as with any other new drug combined with anticoagulants, it is recommended that you ask your physician to monitor your INR when you initiate NeuroAiD™ stroke treatment, as should be done for any change in your prescription medicines.
We have been asking our customers to share with us the list of concomitant medications they have been taking with NeuroAiD™. This list is constantly updated. Do not hesitate to inquire about any specific medication by contacting our customer care Team
Published clinical trials have confirmed that NeuroAiD™ has no effect on thinning the blood or on liver or renal functions; similarly, NeuroAiD™ has no effect on blood pressure.
The initial clinical trials on NeuroAiD™ reported only rare cases of nausea and vomiting for patients taking NeuroAiD™ .In most cases, doctors have advised patients to halve the dose of NeuroAiD™ during the first week and progressively increase it.
Moleac’s pharmacovigilance database records only rare and minor side effects: very rare cases of mild headaches, nausea or vomiting, diarrhea and dizziness, and rare cases of dry throat/increased thirst after several months of NeuroAiD™ stroke treatment, and therefore a need to drink more water.
NeuroAiD™ has been manufactured in the same facility for the past ten years under the recognized principles of current Good Manufacturing Practice (GMP).
The GMP standards are applied to procedures in manufacturing dietary supplements, including approval of raw materials, production and process controls, laboratory testing, and product packaging, labeling, and distribution. These processes are regularly audited by independent health authorities.
The ingredients are carefully selected in compliance with the Chinese Pharmacopoeia’s standards. Every batch of NeuroAiD™ is analyzed thoroughly by third-party independent laboratories to confirm compliance with international standards, ensuring utmost safety for patients.